JBC Anatrace, Inc.

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M102400200 on May 29, 2001

J. Biol. Chem., Vol. 276, Issue 30, 27999-28005, July 27, 2001
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
276/30/27999    most recent
M102400200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wiederschain, D.
Right arrow Articles by Yuan, Z.-M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wiederschain, D.
Right arrow Articles by Yuan, Z.-M.

Evidence for a Distinct Inhibitory Factor in the Regulation of p53 Functional Activity*

Dmitri WiederschainDagger §, JiJie Gu§, and Zhi-Min YuanDagger §

From the § Department of Cancer Cell Biology, Harvard School of Public Health, Boston, Massachusetts 02115 and Dagger  The Program in Biological Sciences in Public Health, Graduate School of Arts and Sciences, Harvard University, Cambridge, Massachusetts 02138

Under normal conditions, tumor suppressor protein p53 exists in the cell in its latent form and is unable to function as a transcription factor. The allosteric model of p53 regulation postulates that the extreme portion of p53 carboxyl terminus (aa 364-393) binds to the core domain of the protein, thereby abrogating specific DNA binding in that region. In this study we propose an alternative mechanism of p53 functional regulation, which involves a separate molecule acting in trans to inhibit p53 transcriptional activity. Through the use of chimeric proteins of p53, p63gamma and p73beta , we show that the extreme COOH-terminal domain of p53 exerts a powerful and specific inhibitory effect on the p73- and p63-driven expression of a reporter gene. Moreover, fusion of p53 extreme COOH terminus to a completely unrelated transcriptional activator Gal4-VP16 also results in significant inhibition of transactivation activity. Since p73, p63, or Gal4-VP16 cannot associate with any part of the p53 molecule, we conclude that p53(aa 364-393) represses transcriptional activity of chimeric proteins and p53 itself through the binding of external negative modulator(s) in that region and not by the allosteric mechanism of regulation. In accordance with the "distinct inhibitor" hypothesis, the activity of wild type p53 is substantially increased by overexpression of chimeric proteins bearing p53(aa 364-393), which might be due to the competitive removal of transcriptional inhibitor(s). Our findings provide the basis for the identification of such negative modulators of p53 transcriptional activity.


* This work was supported by the startup package from the Harvard School of Public Health and Graduate School of Arts and Sciences of Harvard University.The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

To whom correspondence should be addressed: Dept. of Cancer Cell Biology (Bldg. 1, Rm. 209), Harvard School of Public Health, 665 Huntington Ave., Boston, MA 02115. Tel.: 617-432-0763; Fax: 617-432-0107; E-mail: zyuan@hsph.harvard.edu.


Copyright © 2001 by The American Society for Biochemistry and Molecular Biology, Inc.


This article has been cited by other articles:


Home page
Cancer Res.Home page
Y. Tang and C. Eng
PTEN Autoregulates Its Expression by Stabilization of p53 in a Phosphatase-Independent Manner
Cancer Res., January 15, 2006; 66(2): 736 - 742.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
L. Y. Zhao, J. Liu, G. S. Sidhu, Y. Niu, Y. Liu, R. Wang, and D. Liao
Negative Regulation of p53 Functions by Daxx and the Involvement of MDM2
J. Biol. Chem., November 26, 2004; 279(48): 50566 - 50579.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
R. Tomasini, A. A. Samir, A. Carrier, D. Isnardon, B. Cecchinelli, S. Soddu, B. Malissen, J.-C. Dagorn, J. L. Iovanna, and N. J. Dusetti
TP53INP1s and Homeodomain-interacting Protein Kinase-2 (HIPK2) Are Partners in Regulating p53 Activity
J. Biol. Chem., September 26, 2003; 278(39): 37722 - 37729.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Cell Physiol.Home page
B. B. Davis, Y. Dong, and R. H. Weiss
Overexpression of p73 causes apoptosis in vascular smooth muscle cells
Am J Physiol Cell Physiol, January 1, 2003; 284(1): C16 - C23.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. Wong, P.-X. Li, and H. J. Klamut
A Novel p53 Transcriptional Repressor Element (p53TRE) and the Asymmetrical Contribution of Two p53 Binding Sites Modulate the Response of the Placental Transforming Growth Factor-beta Promoter to p53
J. Biol. Chem., July 12, 2002; 277(29): 26699 - 26707.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
C. Yan, H. Wang, and D. D. Boyd
ATF3 Represses 72-kDa Type IV Collagenase (MMP-2) Expression by Antagonizing p53-dependent trans-Activation of the Collagenase Promoter
J. Biol. Chem., March 22, 2002; 277(13): 10804 - 10812.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
H. Mendoza-Alvarez and R. Alvarez-Gonzalez
Regulation of p53 Sequence-specific DNA-binding by Covalent Poly(ADP-ribosyl)ation
J. Biol. Chem., September 21, 2001; 276(39): 36425 - 36430.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
C. Klein, E. Planker, T. Diercks, H. Kessler, K.-P. Kunkele, K. Lang, S. Hansen, and M. Schwaiger
NMR Spectroscopy Reveals the Solution Dimerization Interface of p53 Core Domains Bound to Their Consensus DNA
J. Biol. Chem., December 21, 2001; 276(52): 49020 - 49027.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2001 by the American Society for Biochemistry and Molecular Biology.